Metraipolis › archive › dc_841d1df2a40e

Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives — Europe PMC PMID:42512965

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512965
DOI
10.3390/medicina62071423
License (as archived)
solo-consultazione
Archived
2026-10-18T00:55:41.716Z
SHA-256 of the archived text
d98e0ed49ed46747065472a7fdf1847deca59e9e0c7d1cf7959d47717b59bf77
Stable URL of this page
https://metraipolis.com/documento/dc_841d1df2a40e

How to cite

Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives — Europe PMC PMID:42512965 — Europe PMC (en), https://europepmc.org/article/MED/42512965 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_841d1df2a40e (Metraipolis archive dc_841d1df2a40e, sha256 d98e0ed49ed46747065472a7fdf1847deca59e9e0c7d1cf7959d47717b59bf77)
BibTeX
@misc{dc841d1df2a40e,
  title = {Tezepelumab in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Clinical Evidence, and Therapeutic Perspectives — Europe PMC PMID:42512965},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512965},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_841d1df2a40e; sha256 d98e0ed49ed46747065472a7fdf1847deca59e9e0c7d1cf7959d47717b59bf77},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512965. Agents can read the archived copy with the MCP tool read_document.